Ariane van der Straten, PhD, is an expert in female-initiated HIV-prevention methods. Her research focuses on acceptability and adherence to new biomedical HIV-prevention methods and multipurpose technologies for contraception and HIV prevention.
She has led or participated in the development and implementation of major research projects in Africa and the U.S., including clinical trials of diaphragm and gel, oral, and vagina Tenofovir-based pre-exposure prophylaxis and vaginal rings. Dr. van der Straten has also led several studies focusing on adherence-related issues in the context of prevention trials.
Currently, she is working on a large multidisciplinary project to develop and test the use of a long-lasting, injectable, biodegradable, HIV-prevention device. Dr. van der Straten is an active member of the Women's Global Health Imperative (WGHI), which conducts rigorous epidemiologic, biomedical, and sociobehavioral research to identify and intervene on factors that affect infectious disease and chronic health outcomes.
In addition, Dr. van der Straten serves as a professor at the University of California, San Francisco.